March 31, 2003

1 Min Read
Nutri Pharma


Nutri Pharma

AMERSHAM, Norway--Nutri Pharma is seekingindustrial partners to promote its soy composition Abacor, which it noted hasbeen shown in a recent study to lower cholesterol and serum lipids better thanmany other commercially available soy proteins. The randomized, double blindstudy was conducted in cooperation with the German Institute for Food Research.Nutri Pharma (www.nutripharma.com)holds a patent covering the use of this soy composition in preventing andtreating cardiovascular diseases.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like